GSA Capital Partners’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-11,385
Closed -$687K 2162
2016
Q2
$687K Buy
11,385
+5,698
+100% +$323K 0.04% 881
2016
Q1
$261K Sell
5,687
-1,816
-24% -$65.9K 0.02% 1373
2015
Q4
$363K Sell
7,503
-28,035
-79% -$1.21M 0.02% 1356
2015
Q3
$1.51M Sell
35,538
-56,172
-61% -$2.78M 0.07% 393
2015
Q2
$5.24M Buy
91,710
+73,374
+400% +$4.52M 0.2% 49
2015
Q1
$1.18M Sell
18,336
-10,470
-36% -$600K 0.05% 723
2014
Q4
$1.44M Buy
+28,806
New +$1.5M 0.1% 264
2014
Q3
Sell
-19,010
Closed -$733K 2170
2014
Q2
$733K Sell
19,010
-44,626
-70% -$1.5M 0.03% 888
2014
Q1
$2.05M Buy
+63,636
New +$2.35M 0.15% 136

Other funds holding MDVN

GSA Capital Partners's MDVN Position: Q3 2016 in Review

GSA Capital Partners sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 11,385 shares — an estimated $687K sold.

GSA Capital Partners first reported a position in MDVN in Q1 2014 and held it in 9 quarters. The position peaked at $5.24M in Q2 2015. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • GSA Capital Partners reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • GSA Capital Partners sold 11,385 MEDIVATION, INC. shares in Q3 2016, an estimated $687K.
  • GSA Capital Partners first reported a position in MEDIVATION, INC. in Q1 2014 and held it in 9 quarters.
  • GSA Capital Partners's MEDIVATION, INC. position peaked at $5.24M in Q2 2015.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on GSA Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.